Company Monitoring Page for Biomarin

latest headlines for company on cafepharma

FDA Closing In on November Expert Panel Date for BioMarin, Sarepta Drugs
TheStreet.com
Mon, 07/20/15 - 02:37 pm
Tags:
FDA, Biomarin, advisory panels, eteplirsen, Sarepta Therapeutics, drisapersen, Duchenne Muscular Dystrophy
BioMarin shines as dwarfism drug boosts growth in children
Fierce Biotech
Thu, 06/18/15 - 10:28 am
Tags:
Biomarin, dwarfism, BMN-111
FDA finally responds to demand for Duchenne Muscular Dystrophy guidance
BioPharma Dive
Wed, 06/10/15 - 10:58 am
Tags:
FDA, Duchenne Muscular Dystrophy, Saretpa, PTC Therapeutics, Pfizer, Biomarin
Upcoming Events: A Dosing Decision For BioMarin, Plus Roche To Get Alzheimer's Data
Seeking Alpha
Mon, 05/25/15 - 12:41 pm
Tags:
Biomarin, Roche, Alzheimer's disease, RG1577
These biotech names are ripe for mergers: Analysts
CNBC
Sun, 05/10/15 - 02:04 pm
Tags:
Biomarin, Sanofi, Shire, Gilead Sciences, Vertex Pharmaceuticals, Ariad Pharmaceuticals
Why These 4 Biotech Stocks Could Be the Next Buyout Targets
24/7 Wall St
Thu, 05/7/15 - 09:23 am
Tags:
biotech, M&A, Biomarin, Bluebird Bio, Incyte, Vertex Pharmaceuticals
Why BioMarin’s New Drug Application is Good News for Sarepta Therapuetics
Fierce Pharma Marketing
Wed, 05/6/15 - 11:44 am
Tags:
Biomarin, Sarepta Therapeutics, drisapersen, Duchenne Muscular Dystrophy
4 Big Biopharma Deals We Might See In 2015
Seeking Alpha
Fri, 04/17/15 - 08:42 am
Tags:
AbbVie, AstraZeneca, Biomarin, Bristol-Myers Squibb, Celgene, Gilead Sciences, GSK, Hospira, Jazz Pharmaceuticals, Merck, Seattle Genetics, Shire
4 big biopharma deals we might see in 2015
BioPharma Dive
Mon, 04/6/15 - 10:51 am
Tags:
M&A, Merck, Jazz Pharmaceuticals, Shire, Biomarin, Gilead Sciences, Seattle Genetics, Pfizer, Celgene
Biotech's next buzz: Gene therapy?
CNBC
Tue, 03/31/15 - 03:59 pm
Tags:
biotech, gene therapy, Spark Therapeutics, Biomarin, Avalanche Biotechnologies
Shire, BioMarin and the snowball effect of buyout rumors
Fierce Biotech
Fri, 03/27/15 - 12:05 pm
Tags:
Shire, Biomarin, M&A
The Biotech Selloff: It’s Déjà Vu All Over Again
Barron's
Thu, 03/26/15 - 10:13 am
Tags:
biotech, Alnylam, Biomarin, Incyte, Isis Pharmaceuticals, Vertex Pharmaceuticals
The Top 10 Biotech Companies In The U.S.
Forbes
Fri, 03/20/15 - 01:13 pm
Tags:
biotech, Gilead Sciences, Amgen, Celgene, Biogen Idec, Regeneron, Alexion, Vertex Pharmaceuticals, Illumina, Biomarin, Agilent
The Top 10 Biotech Companies In The U.S.
Forbes
Fri, 03/6/15 - 11:43 am
Tags:
biotech, Gilead Sciences, Amgen, Celgene, Biogen Idec, Regeneron, Alexion, Vertex Pharmaceuticals, Illumina, Biomarin, Agilent
The Next 3 Likely Biotech Buyout Candidates
24/7 Wall St
Fri, 03/6/15 - 08:38 am
Tags:
biotech, Biomarin, Bluebird Bio, Incyte, M&A
BioMarin To Report Revenue In-line With Consensus, Wedbush Says
Benzinga
Sat, 02/21/15 - 10:27 am
Tags:
Biomarin, earnings
Rare feat: BioMarin rewrites playbook for small-market drug approvals
Bizjournals.com
Tue, 01/27/15 - 09:41 am
Tags:
Biomarin, orphan drugs, BMN-190, Batten disease
Booming biotechs bank $2.7B in follow-on cash
Fierce Biotech
Fri, 01/23/15 - 03:38 pm
Tags:
biotech, Prosensa, Biomarin, Zafgen, Alnylam, Auspex, Puma Biotechnology, Arena Pharmaceuticals, Radius Health, Intrexon
BioMarin CEO Angers Sarepta CEO With Slides Comparing Trial Data
WSJ Pharmalot
Sat, 01/17/15 - 10:45 am
Tags:
Biomarin, Sarepta Therapeutics, Duchenne Muscular Dystrophy
Biotech Rivalry Gets Nasty in Mudslinging Battle Over Data
Bloomberg
Thu, 01/15/15 - 09:28 pm
Tags:
Sarepta Therapeutics, Biomarin, Duchenne Muscular Dystrophy

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.